Literature DB >> 18043109

Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer.

Mitsuru Ishizuka1, Hitoshi Nagata, Kazutoshi Takagi, Toru Horie, Keiichi Kubota.   

Abstract

OBJECTIVE: To investigate the significance of preoperative Glasgow prognostic score (GPS) for postoperative prognostication of patients with colorectal cancer.
BACKGROUND: Recent studies have revealed that the GPS, an inflammation-based prognostic score that includes only C-reactive protein (CRP) and albumin, is a useful tool for predicting postoperative outcome in cancer patients. However, few studies have investigated the GPS in the field of colorectal surgery.
METHODS: The GPS was calculated on the basis of admission data as follows: patients with an elevated level of both CRP (>10 mg/L) and hypoalbuminemia (Alb <35 g/L) were allocated a score of 2, and patients showing 1 or none of these blood chemistry abnormalities were allocated a score of 1 or 0, respectively. Prognostic significance was analyzed by univariate and multivariate analyses.
RESULTS: A total of 315 patients were evaluated. Kaplan-Meier analysis and log-rank test revealed that a higher GPS predicted a higher risk of postoperative mortality (P < 0.01). Univariate analyses revealed that postoperative TNM was the most sensitive predictor of postoperative mortality (odds ratio, 0.148; 95% confidence interval, 0.072-0.304; P < 0.0001). Multivariate analyses using factors such as age, sex, tumor site, serum carcinoembryonic antigen, CA19-9, CA72-4, CRP, albumin, and GPS revealed that GPS (odds ratio, 0.165; 95% confidence interval, 0.037-0.732; P = 0.0177) was associated with postoperative mortality.
CONCLUSIONS: Preoperative GPS is considered to be a useful predictor of postoperative mortality in patients with colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18043109     DOI: 10.1097/SLA.0b013e3181454171

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  109 in total

1.  Lower albumin levels in African Americans at colon cancer diagnosis: a potential explanation for outcome disparities between groups?

Authors:  Aja S McCutchen; Juan Carlos Munoz; Lacie Brenner; Peter Wludyka; Kenneth J Vega
Journal:  Int J Colorectal Dis       Date:  2011-01-27       Impact factor: 2.571

2.  Modified glasgow prognostic score as a prognostic factor in gastriccancer patients: a systematic review and meta-analysis.

Authors:  Xinwu Zhang; Xi Chen; Tao Wu; Yan Zhang; Kun Yan; Xiaoli Sun
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection.

Authors:  Akira Iwaku; Akiyoshi Kinoshita; Hiroshi Onoda; Nao Fushiya; Hirokazu Nishino; Masato Matsushima; Hisao Tajiri
Journal:  Med Oncol       Date:  2013-12-06       Impact factor: 3.064

4.  Adherence to the ERAS protocol is Associated with 5-Year Survival After Colorectal Cancer Surgery: A Retrospective Cohort Study.

Authors:  Ulf O Gustafsson; Henrik Oppelstrup; Anders Thorell; Jonas Nygren; Olle Ljungqvist
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

5.  Systemic inflammatory response associated with distant metastasis of T1 or T2 colorectal cancer.

Authors:  Mitsuru Ishizuka; Hitoshi Nagata; Kazutoshi Takagi; Keiichi Kubota
Journal:  Dig Dis Sci       Date:  2010-03-03       Impact factor: 3.199

6.  Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.

Authors:  Susumu Inamoto; Kenji Kawada; Ryosuke Okamura; Koya Hida; Yoshiharu Sakai
Journal:  Int J Colorectal Dis       Date:  2019-06-08       Impact factor: 2.571

7.  Effect of pre-operative red blood cell distribution on cancer stage and morbidity rate in patients with pancreatic cancer.

Authors:  A Yilmaz; Fu Malya; G Ozturk; B Citgez; Y Ozdenkaya; C Ersavas; Af Agan; H Senturk; O Karatepe
Journal:  Int J Clin Exp Med       Date:  2014-09-15

8.  Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Eiji Noda; Hiroshi Ohtani; Yukio Nishiguchi; Kosei Hirakawa
Journal:  Surg Today       Date:  2014-05-10       Impact factor: 2.549

9.  Glasgow Prognostic Score is superior to ECOG PS as a prognostic factor in patients with gastric cancer with peritoneal seeding.

Authors:  Shu-Qiang Yuan; Run-Cong Nie; Yong-Ming Chen; Hai-Bo Qiu; Xiao-Ping Li; Xiao-Jiang Chen; Li-Pu Xu; Li-Fang Yang; Xiao-Wei Sun; Yuan-Fang Li; Zhi-Wei Zhou; Shi Chen; Ying-Bo Chen
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

10.  The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer.

Authors:  C H Richards; E F Leitch; P G Horgan; J H Anderson; R F McKee; D C McMillan
Journal:  Br J Cancer       Date:  2010-09-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.